ACAD ACADIA Pharmaceuticals Inc. - Common Stock
$29.17
株価 · 8月 18, 2026
ファンダメンタルズ（時点） 8月 5, 2026
52週レンジ
$20–$30
93% of range
アナリスト評価
BUY
27 analysts
目標株価
$34
+16% upside
P/E (TTM)
12.7
ROE
38.1%
純利益率
36.5%
ACADIA Pharmaceuticals Inc. - Common Stock について Wikipediaからの企業概要
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, California.
続きを読む
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, California.
Product development
Nuplazid, a drug developed by Acadia in the late 1990s, "was designed to stimulate a subset of the brain’s serotonin receptors, or the proteins that govern memory, cognition and learning." On April 29, 2016, the FDA approved Acadia's drug, Nuplazid, for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. Nuplazid is the trade name for Acadia's proprietary molecule, pimavanserin, a selective serotonin inverse agonist preferentially targeting 5-HT2a receptors. Acadia had partnered with Biovail in the late-stage clinical testing of the drug, which showed trial failures as of 2009.
Acadia is running multiple Phase 2 and Phase 3 trials with pimavanserin in several central nervous system conditions: dementia-related psychosis, major depressive disorder, schizophrenia inadequate response, and schizophrenia negative symptoms.
As of 1997, Acadia was among several companies that licensed compounds from Genzyme's small-molecule compound library.
In 2023, the FDA approved trofinetide (marketed as Daybue) for use in Rett syndrome.
History
Acadia started in 1993 as Receptor Technologies, based in Winooski, Vermont. In 1997, the company relocated all operations and management from Vermont to San Diego, California, as a strategic move to garner partnerships with other biotechnology companies. However, the company also had an office in Denmark, in which it received a crucial part of its early investments from BankInvest, under managing director Florian Schönharting, Kommunernes Pensionsforsikring A/S and Dansk Kapitalanlæg Aktieselskab as well as private investor Lars Christiansen. At the time, the company had fifty employees, fourteen of whom were in the Denmark office. The focus of the company in its early years was on genetic screens for receptors, aiming to accelerate early stage drug discovery.
The company planned to conduct an initial public offering (IPO) consisting of 31.6% of the company in 2001, with the intention of raising US$64 million and listing on the NASDAQ exchange under the symbol ACAD. At the time, Acadia and Allergan were collaborating on development of a treatment for glaucoma, and Allergan would retain a 6.3% ownership stake in Acadia after the IPO. However, the company's IPO, which ultimately took place in May 2004, did not fare as well as expected and netted only US$35 million. At the time, the company had five drugs in development and was running two in human trials. The company had a subsequent round of stock offering in May 2007 which raised US$102 million.
In September 2020, Acadia Pharmaceuticals acquired clinical-stage biotechnology company CerSci Therapeutics.
Corporate governance
In 2001, the company's chief executive officer at the time, Leonard R. Borrmann, left Acadia to lead Maret Pharmaceuticals. He was succeeded by Uli Hacksell, who left Acadia to lead Cerecor at the beginning of 2016.
== References ==
出典: Wikipedia (英語), CC BY-SA 4.0 · Wikipediaで表示 ↗
ACAD 株価スナップショット 価格、時価総額、P/E、EPS、ROE、負債/資本、52週レンジ
株価
$29.17
時価総額
$4.97B
P/E (TTM)
12.7
EPS（TTM）
$2.30
収益（TTM）
$1.07B
配当利回り
—
ROE
38.1%
負債/自己資本
—
52週レンジ
$20 – $30
ACAD 株価チャート 技術指標付きの日次 OHLCV — パン、ズーム、ビューのカスタマイズ
Configure
10年間のパフォーマンス 収益、純利益、利益率、EPSのトレンド
収益と純利益
$1.07B
2016-12-31
→
2025-12-31
EPS
$2.30
2020-12-31
→
2025-12-31
フリーキャッシュフロー
$105M
2016-12-31
→
2025-12-31
利益率
36.5%
2016-12-31
→
2023-12-31
バリュエーション P/E、P/S、P/B、EV/EBITDA比率 — 株は割高か割安か？
指標
5年トレンド
ACAD
競合中央値
P/E (TTM)
12.7
13.2
P/S (TTM) (株価売上高倍率（TTM）)
4.6
55.3
P/B (株価純資産倍率)
4.0
3.5
Price / FCF (株価FCF倍率)
47.2
—
収益性 粗利益率、営業利益率、純利益率、ROE、ROA、ROIC
指標
5年トレンド
ACAD
競合中央値
Operating Margin (営業利益率)
9.8%
—
Net Profit Margin (純利益率)
36.5%
-151.2%
ROA
28.4%
-42.2%
ROE
38.1%
-52.8%
ROIC
24.0%
—
財務健全性 負債、流動性、支払能力 — バランスシートの健全性
指標
5年トレンド
ACAD
競合中央値
Current Ratio (流動比率)
3.8
10.3
Quick Ratio (クイックレシオ)
1.1
—
成長 収益、EPS、純利益の成長率：前年比、3年CAGR、5年CAGR
指標
5年トレンド
ACAD
競合中央値
Revenue YoY (収益（前年比）)
11.9%
—
Revenue CAGR 3Y (収益（3年CAGR）)
27.5%
—
Revenue CAGR 5Y (収益（5年CAGR）)
19.4%
—
EPS YoY
69.1%
—
Net Income YoY (純利益（前年比）)
72.7%
—
資本効率 総資産回転率、棚卸資産回転率、売掛金回転率
指標
5年トレンド
ACAD
競合中央値
ACAD アナリストコンセンサス 強気・弱気のアナリストの見解、12ヶ月の目標株価、アップサイド
買い
27 アナリスト
- 強い買い 7 25.9%
- 買い 14 51.9%
- 保有 5 18.5%
- 売り 1 3.7%
- 強い売り 0 0.0%
12ヶ月目標株価
20 アナリスト · 2026-08-18
中央値
$36.00
現在
$29.17
安値
$17.00
高値
$49.00
中央値ターゲット
$36.00
+23.4%
平均値ターゲット
$33.85
+16.0%
決算履歴 EPS実績 vs 予想、サプライズ%、達成率、次回決算日
平均サプライズ
0.30%
| 期間 | EPS Actual | EPS 予想 | サプライズ |
|---|---|---|---|
| 2026年6月30日 | $0.18 | $0.06 | 0.12% |
| 2026年3月31日 | $0.02 | $0.06 | -0.04% |
| 2025年12月31日 | $1.60 | $0.14 | 1.5% |
| 2025年9月30日 | $0.42 | $0.15 | 0.27% |
| 2025年6月30日 | $0.16 | $0.14 | 0.02% |
| 2025年3月31日 | $0.11 | $0.11 | -0.00% |
同業他社比較（GICSサブインダストリー） 主要メトリクスとセクターピアの比較
| ティッカー | 時価総額 | P/E | 売上高 YoY | 純利益率 | ROE | 粗利益率 |
|---|---|---|---|---|---|---|
| ACAD | $4.55B | 11.6 | 11.9% | 36.5% | 38.1% | — |
| DNTH | $1.78B | -9.8 | -67.3% | -7973.3% | -40.8% | — |
| CAI | $7.62B | -8.4 | 97.0% | -8.4% | -13.2% | — |
| PTCT | $6.19B | 9.8 | 114.5% | 39.4% | -331.5% | — |
| TVTX | $3.47B | -131.8 | 110.5% | -5.2% | -34.6% | — |
| DYN | $3.23B | -5.6 | — | — | -57.8% | — |
| CELC | $4.81B | -26.3 | — | — | -244.3% | — |
| RLAY | $1.47B | -5.3 | 53.4% | -1800.6% | -44.9% | — |
| PBLS | — | — | — | — | — | — |
完全なファンダメンタルズ 年次別全指標 — 損益計算書、貸借対照表、キャッシュフロー
損益計算書 16
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.07B | $958M | $726M | $517M | $484M | $442M | $339M | $224M | $125M | $17M | $61.0K | $120.0K | |
| Cost of Revenue | $89M | $82M | $42M | $10M | $19M | $10M | $11M | $12M | $9M | $3M | · | · | |
| Gross Profit | · | · | $685M | $507M | $473M | $432M | $328M | $211M | $116M | $14M | · | · | |
| R&D Expense | $329M | $303M | $352M | $362M | $239M | $319M | $240M | $187M | $149M | $99M | $74M | $61M | |
| SG&A Expense | $549M | $488M | $407M | $369M | $396M | $389M | $326M | $266M | $255M | $186M | $88M | $33M | |
| Operating Expenses | $967M | $727M | $800M | $741M | $655M | $728M | $586M | $471M | $417M | $290M | $165M | $93M | |
| Operating Income | $105M | $231M | $-73M | $-224M | $-170M | $-287M | $-247M | $-247M | $-292M | $-273M | $-165M | $-93M | |
| Other Non-op | $2M | $2M | $5M | $4M | $2M | $-997.0K | $997.0K | $-2M | · | · | · | · | |
| Pretax Income | $139M | $258M | $-51M | $-213M | $-168M | $-281M | $-234M | $-244M | $-288M | $-270M | $-164M | $-92M | |
| Income Tax | $-252M | $32M | $10M | $3M | $351.0K | $611.0K | $876.0K | $1M | $1M | $1M | $330.0K | $0 | |
| Net Income | $391M | $226M | $-61M | $-216M | $-168M | $-282M | $-235M | $-245M | $-289M | $-271M | $-164M | $-92M | |
| EPS (Basic) | $2.32 | $1.37 | $-0.37 | $-1.34 | $-1.05 | $-1.79 | · | · | · | · | · | · | |
| EPS (Diluted) | $2.30 | $1.36 | $-0.37 | $-1.34 | $-1.05 | $-1.79 | · | · | · | · | · | · | |
| Shares (Basic) | 168,356,000 | 165,717,000 | 163,819,000 | 161,683,000 | 160,493 | 157,331 | · | · | · | · | · | · | |
| Shares (Diluted) | 169,919,000 | 166,362,000 | 163,819,000 | 161,683,000 | 160,493 | 157,331 | · | · | · | · | · | · | |
| EBITDA | $105M | $231M | $-73M | $-224M | $-170M | $-287M | $-247M | $-247M | $-292M | $-273M | $-165M | $-93M |
貸借対照表 25
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $178M | $320M | $189M | $115M | $147M | $326M | $190M | $135M | $69M | $164M | $102M | $62M | |
| Receivables | $121M | $99M | $98M | $62M | $64M | $48M | $36M | $26M | $17M | $6M | · | · | |
| Inventory | $111M | $92M | $40M | $12M | $14M | $10M | $6M | $4M | $5M | $4M | · | · | |
| Prepaid Expense | $60M | $56M | $39M | $21M | $24M | $26M | $19M | $21M | $8M | $8M | $2M | $1M | |
| Current Assets | $1.06B | $938M | $616M | $508M | $618M | $718M | $760M | $526M | $373M | $548M | $219M | $325M | |
| PP&E (Net) | $8M | $4M | $5M | $6M | $8M | $9M | $3M | $3M | $3M | $3M | $2M | $553.0K | |
| PP&E (Gross) | $17M | $14M | $14M | $14M | $14M | $13M | $9M | $8M | $7M | $6M | $5M | $3M | |
| Accum. Depreciation | $9M | $10M | $10M | $8M | $6M | $4M | $5M | $4M | $4M | $3M | $3M | $2M | |
| Intangibles | $109M | $120M | $65M | $0 | $0 | $1M | $3M | $4M | $6M | $7M | · | · | |
| Other Non-current Assets | $4M | $359.0K | $476.0K | $8M | $4M | $2M | $3M | $2M | $354.0K | $785.0K | $329.0K | $287.0K | |
| Total Assets | $1.56B | $1.19B | $749M | $588M | $700M | $783M | $783M | $540M | $385M | $561M | $222M | $325M | |
| Accounts Payable | $11M | $16M | $18M | $13M | $7M | $8M | $7M | $3M | $9M | $4M | $2M | $2M | |
| Accrued Liabilities | $266M | $379M | $237M | $113M | $89M | $97M | $68M | $56M | $40M | $36M | $20M | $14M | |
| Current Liabilities | $277M | $395M | $254M | $126M | $96M | $106M | $75M | $60M | $49M | $43M | $22M | $16M | |
| Capital Leases | $41M | $42M | $48M | $53M | $56M | $44M | $6M | · | · | · | · | · | |
| Deferred Tax | $11M | $11M | $12M | $13M | $14M | $13M | $3M | · | · | · | · | · | |
| Other Non-current Liabilities | $19M | $18M | $15M | $9M | $7M | $5M | $3M | $2M | · | · | · | · | |
| Total Liabilities | $337M | $455M | $317M | $187M | $159M | $156M | $84M | $61M | $49M | $43M | $22M | $16M | |
| Common Stock | $16.0K | $16.0K | $16.0K | $16.0K | $16.0K | $16.0K | $15.0K | $14.0K | $12.0K | $12.0K | $10.0K | $10.0K | |
| Paid-in Capital | · | · | · | · | · | · | · | · | · | $1.45B | $862M | $808M | |
| Retained Earnings | $-1.81B | $-2.20B | $-2.43B | $-2.37B | $-2.15B | $-1.99B | $-1.70B | $-1.47B | $-1.22B | $-934M | $-663M | $-498M | |
| AOCI | $1M | $292.0K | $24.0K | $-975.0K | $-192.0K | $36.0K | $297.0K | $-372.0K | $-399.0K | $106.0K | $11.0K | $-9.0K | |
| Stockholders' Equity | $1.23B | $733M | $432M | $400M | $541M | $627M | $699M | $479M | $335M | $518M | $200M | $309M | |
| Liabilities + Equity | $1.56B | $1.19B | $749M | $588M | $700M | $783M | $783M | $540M | $385M | $561M | $222M | $325M | |
| Shares Outstanding | 170,309,376 | 166,708,856 | 164,650,219 | 162,064,872 | 161,012,695 | 159,637,771 | 155,275,300 | 143,853,597 | 124,410,552 | 121,367,169 | 101,938,702 | 100,047,331 |
キャッシュフロー 13
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | · | · | · | · | $206.0K | |
| Stock-based Comp | $52M | $67M | $66M | $68M | $64M | $84M | $82M | $82M | $76M | $55M | $40M | $16M | |
| Deferred Tax | $-250M | $0 | $0 | $3M | $351.0K | · | · | · | · | · | · | · | |
| Amort. of Intangibles | $11M | $15M | $4M | $0 | $1M | $1M | $1M | $1M | $1M | $985.0K | $0 | $0 | |
| Operating Cash Flow | $110M | $158M | $17M | $-114M | $-126M | $-136M | $-151M | $-167M | $-218M | $-208M | $-122M | $-66M | |
| CapEx | $5M | $523.0K | $50.0K | $0 | $1M | $8M | $1M | $2M | $812.0K | $2M | $2M | $180.0K | |
| Investing Cash Flow | $-303M | $-31M | $32M | $73M | $-71M | $193M | $-166M | $-71M | $92M | $-262M | · | · | |
| Stock Issued | $50M | $7M | $25M | $8M | $18M | $81M | $372M | $307M | $31M | $519M | $15M | $204M | |
| Net Stock Activity | $50M | $7M | $25M | $8M | $18M | $81M | $372M | $307M | $31M | $519M | $15M | $204M | |
| Financing Cash Flow | $50M | $7M | $25M | $8M | $18M | $81M | $372M | $307M | $31M | $534M | · | · | |
| Net Change in Cash | $-143M | $134M | $74M | $-33M | $-179M | $137M | $55M | $68M | $-94M | $63M | $40M | $50M | |
| Taxes Paid | $25M | $20M | $6M | $2M | $1M | $1M | $2M | $1M | $1M | $-365.0K | $415.0K | · | |
| Free Cash Flow | $105M | $157M | $17M | $-114M | $-127M | $-144M | $-152M | $-170M | $-219M | $-212M | $-124M | $-67M |
収益性 8
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | 94.3% | 98.0% | 97.8% | 97.7% | 96.7% | 94.5% | 92.7% | 82.2% | · | · | |
| Operating Margin | 9.8% | 24.1% | -10.1% | -43.2% | -35.2% | -64.9% | -72.7% | -110.6% | -234.1% | -1574.1% | -269855.7% | -77691.7% | |
| Net Margin | 36.5% | 23.6% | -8.4% | -41.8% | -34.7% | -63.7% | -69.4% | -109.6% | -231.7% | -1565.9% | -269578.7% | -77062.5% | |
| Pretax Margin | 13.0% | 26.9% | -7.0% | -41.3% | -34.6% | -63.6% | -69.1% | -109.0% | -230.8% | -1558.2% | -269037.7% | · | |
| EBITDA Margin | 9.8% | 24.1% | -10.1% | -43.2% | -35.2% | -64.9% | -72.7% | -110.6% | -234.1% | -1574.1% | -269855.7% | -77691.7% | |
| ROA | 28.4% | 23.4% | -9.2% | -33.5% | -22.6% | -36.0% | -35.5% | -53.0% | -61.2% | -69.3% | -60.1% | -35.9% | |
| ROE | 38.1% | 34.6% | -15.4% | -52.3% | -30.3% | -43.9% | -33.9% | -69.8% | -67.8% | -75.6% | -64.6% | -37.6% | |
| ROIC | 24.0% | 27.6% | -20.4% | -56.5% | -31.6% | -45.8% | -35.4% | -51.9% | -87.5% | -52.9% | -82.6% | · |
流動性と支払能力 2
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.8 | 2.4 | 2.4 | 4.0 | 6.4 | 6.8 | 10.2 | 8.8 | 7.6 | 12.9 | 10.0 | 20.5 | |
| Quick Ratio | 1.1 | 1.1 | 1.1 | 1.4 | 2.2 | 3.5 | 3.0 | 2.7 | 1.8 | 4.0 | 4.7 | 3.9 |
効率性 3
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 1.0 | 1.1 | 0.8 | 0.7 | 0.6 | 0.5 | 0.5 | 0.3 | 0.0 | 0.0 | 0.0 | |
| Inventory Turnover | 0.9 | 1.2 | 1.6 | 0.8 | 0.9 | 1.3 | 2.2 | · | 1.9 | 1.5 | · | · | |
| Receivables Turnover | 9.7 | 9.7 | 9.1 | 8.2 | 8.6 | 10.5 | 11.0 | 10.3 | 10.7 | 5.9 | · | · |
成長率 5
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 11.9% | 31.9% | 40.5% | 6.8% | 9.6% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 27.5% | 25.5% | 18.0% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 19.4% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 69.1% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 72.7% | · | · | · | · | · | · | · | · | · | · | · |
バリュエーション（TTM） 10
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.07B | $958M | $726M | $517M | $484M | $442M | $339M | $224M | $125M | $17M | $61.0K | $120.0K | |
| Net Income TTM | $391M | $226M | $-61M | $-216M | $-168M | $-282M | $-235M | $-245M | $-289M | $-271M | $-164M | $-92M | |
| Market Cap | $4.55B | $3.06B | $5.16B | $2.58B | $3.76B | $8.53B | $6.64B | $2.33B | $3.75B | $3.50B | $3.63B | $3.18B | |
| P/E | 11.6 | 13.5 | -84.6 | -11.9 | -22.2 | -29.9 | · | · | · | · | · | · | |
| P/S | 4.2 | 3.2 | 7.1 | 5.0 | 7.8 | 19.3 | 19.6 | 10.4 | 30.0 | 202.0 | 59575.7 | 26470.9 | |
| P/B | 3.7 | 4.2 | 11.9 | 6.4 | 6.9 | 13.6 | 9.5 | 4.9 | 11.2 | 6.8 | 18.2 | 10.3 | |
| P / Tangible Book | 4.1 | 5.0 | 14.1 | 6.4 | 6.9 | 13.6 | · | · | · | · | · | · | |
| P / Cash Flow | 41.4 | 19.4 | 308.7 | -22.6 | -29.9 | -62.7 | -44.0 | -13.9 | -17.2 | -16.6 | -29.8 | -47.8 | |
| P / FCF | 43.3 | 19.5 | 309.6 | -22.6 | -29.6 | -59.4 | -43.6 | -13.7 | -17.1 | -16.5 | -29.3 | -47.7 | |
| Earnings Yield | 8.6% | 7.4% | -1.2% | -8.4% | -4.5% | -3.4% | · | · | · | · | · | · |
損益計算書 16
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $308M | $268M | $284M | $279M | $265M | $244M | $260M | $250M | $242M | $206M | $231M | $212M | $165M | $118M | $136M | $131M | |
| Cost of Revenue | $28M | $25M | $26M | $22M | $21M | $20M | $22M | $19M | $18M | $23M | $18M | $15M | $7M | $2M | $2M | $2M | |
| Gross Profit | · | · | · | · | · | · | · | · | · | · | $213M | $197M | $158M | $117M | $134M | $129M | |
| R&D Expense | $82M | $77M | $85M | $88M | $78M | $78M | $101M | $67M | $76M | $60M | $67M | $157M | $59M | $69M | $76M | $81M | |
| SG&A Expense | $160M | $171M | $156M | $133M | $134M | $126M | $130M | $133M | $117M | $108M | $111M | $98M | $96M | $101M | $104M | $78M | |
| Operating Expenses | $270M | $273M | $267M | $243M | $232M | $225M | $106M | $219M | $212M | $191M | $196M | $269M | $162M | $172M | $183M | $162M | |
| Operating Income | $38M | $-5M | $17M | $36M | $32M | $19M | $154M | $32M | $30M | $15M | $35M | $-58M | $3M | $-54M | $-46M | $-31M | |
| Other Non-op | $647.0K | $542.0K | $596.0K | $593.0K | $594.0K | $588.0K | $575.0K | $576.0K | $386.0K | $286.0K | $0 | $2M | $-1M | $5M | $2M | $2M | |
| Pretax Income | $46M | $4M | $26M | $45M | $40M | $28M | $161M | $39M | $37M | $21M | $40M | $-52M | $6M | $-45M | $-41M | $-26M | |
| Income Tax | $15M | $344.0K | $-247M | $-27M | $14M | $9M | $17M | $6M | $4M | $4M | $-6M | $13M | $5M | $-2M | $835.0K | $768.0K | |
| Net Income | $32M | $4M | $274M | $72M | $27M | $19M | $144M | $33M | $33M | $17M | $46M | $-65M | $1M | $-43M | $-42M | $-27M | |
| EPS (Basic) | $0.18 | $0.02 | $1.62 | $0.43 | $0.16 | $0.11 | $0.87 | $0.20 | $0.20 | $0.10 | $0.29 | $-0.40 | $0.01 | $-0.27 | $-0.26 | $-0.17 | |
| EPS (Diluted) | $0.18 | $0.02 | $1.61 | $0.42 | $0.16 | $0.11 | $0.86 | $0.20 | $0.20 | $0.10 | $0.29 | $-0.40 | $0.01 | $-0.27 | $-0.26 | $-0.17 | |
| Shares (Basic) | 171,603,000 | 170,517,000 | -335,115,000 | 168,836,000 | 167,827,000 | 166,808,000 | -330,606,000 | 165,974,000 | 165,551,000 | 164,798,000 | -326,136,000 | 164,234,000 | 163,458,000 | 162,263,000 | 128,494 | 161,852 | |
| Shares (Diluted) | 172,851,000 | 172,706,000 | -337,080,000 | 170,650,000 | 168,681,000 | 167,668,000 | -332,613,000 | 166,178,000 | 166,174,000 | 166,623,000 | -327,724,000 | 164,234,000 | 165,046,000 | 162,263,000 | 128,494 | 161,852 | |
| EBITDA | $38M | $-5M | · | $36M | $32M | $19M | · | $32M | $30M | $15M | · | $-58M | $3M | $-54M | · | $-31M |
貸借対照表 24
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $385M | $282M | $178M | $258M | $254M | $218M | $320M | $155M | $177M | $205M | $189M | $98M | $108M | $291M | $115M | $155M | |
| Receivables | $151M | $135M | $121M | $116M | $108M | $106M | $99M | $98M | $104M | $95M | · | $93M | $82M | $66M | · | $56M | |
| Inventory | $109M | $112M | $111M | $106M | $111M | $103M | $92M | $87M | $86M | $67M | · | $25M | $14M | $11M | · | $12M | |
| Prepaid Expense | $69M | $65M | $60M | $61M | $53M | $53M | $56M | $52M | $46M | $43M | · | $38M | $24M | $24M | · | $23M | |
| Current Assets | $1.22B | $1.10B | $1.06B | $1.08B | $961M | $871M | $938M | $788M | $729M | $675M | · | $499M | $493M | $503M | · | $522M | |
| PP&E (Net) | $17M | $15M | $8M | $4M | $4M | $3M | $4M | $4M | $4M | $4M | · | $5M | $5M | $6M | · | $7M | |
| PP&E (Gross) | · | · | $17M | · | · | · | $14M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $9M | · | · | · | $10M | · | · | · | · | · | · | · | · | · | |
| Intangibles | $103M | $106M | $109M | $112M | $114M | $117M | $120M | $106M | $108M | $110M | · | $67M | $68M | $70M | · | · | |
| Other Non-current Assets | $4M | $4M | $4M | $3M | $2M | $1M | $359.0K | $359.0K | $476.0K | $476.0K | · | $475.0K | $11M | $12M | · | $6M | |
| Total Assets | $1.74B | $1.61B | $1.56B | $1.33B | $1.23B | $1.13B | $1.19B | $977M | $914M | $855M | · | $633M | $643M | $655M | · | $602M | |
| Accounts Payable | $45M | $12M | $11M | $22M | $20M | $18M | $16M | $19M | $20M | $19M | · | $12M | $19M | $17M | · | $10M | |
| Accrued Liabilities | $317M | $293M | $266M | $335M | $310M | $284M | $379M | $325M | $318M | $311M | · | $197M | $169M | $207M | · | $107M | |
| Current Liabilities | $361M | $306M | $277M | $357M | $330M | $303M | $395M | $344M | $338M | $331M | · | $210M | $188M | $224M | · | $117M | |
| Capital Leases | $60M | $39M | $41M | $43M | $45M | $45M | $42M | $40M | $47M | $49M | · | $48M | $50M | $51M | · | $54M | |
| Deferred Tax | · | · | $11M | · | · | · | $11M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $15M | $13M | $19M | $14M | $29M | $20M | $18M | $15M | $12M | $11M | · | $13M | $9M | $5M | · | $6M | |
| Total Liabilities | $436M | $357M | $337M | $413M | $403M | $367M | $455M | $400M | $397M | $391M | · | $270M | $247M | $281M | · | $177M | |
| Common Stock | $16.0K | $16.0K | $16.0K | $16.0K | $16.0K | $16.0K | $16.0K | $16.0K | $16.0K | $16.0K | · | $16.0K | $16.0K | $16.0K | · | $16.0K | |
| Retained Earnings | $-1.78B | $-1.81B | $-1.81B | $-2.09B | $-2.16B | $-2.19B | $-2.20B | $-2.35B | $-2.38B | $-2.41B | · | $-2.48B | $-2.41B | $-2.41B | · | $-2.33B | |
| AOCI | $-958.0K | $-563.0K | $1M | $989.0K | $406.0K | $437.0K | $292.0K | $858.0K | $-339.0K | $-229.0K | · | $-319.0K | $-535.0K | $-220.0K | · | $-1M | |
| Stockholders' Equity | $1.31B | $1.25B | $1.23B | $917M | $822M | $765M | $733M | $577M | $517M | $464M | $432M | $362M | $396M | $374M | $400M | $426M | |
| Liabilities + Equity | $1.74B | $1.61B | $1.56B | $1.33B | $1.23B | $1.13B | $1.19B | $977M | $914M | $855M | · | $633M | $643M | $655M | · | $602M | |
| Shares Outstanding | 172,132,442 | 171,086,205 | 170,309,376 | 169,146,043 | 168,607,881 | 167,116,045 | 166,708,856 | 166,351,715 | 165,853,301 | 164,959,736 | · | 163,968,949 | 163,355,787 | 162,384,178 | · | 161,871,806 |
キャッシュフロー 10
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $17M | $15M | $13M | $13M | $14M | $11M | $10M | $26M | $16M | $15M | $18M | $19M | $15M | $15M | $14M | $18M | |
| Amort. of Intangibles | $3M | $3M | $3M | $3M | $3M | $3M | $5M | $2M | $2M | $5M | $1M | $1M | $1M | $0 | $0 | $0 | |
| Operating Cash Flow | $101M | $34M | $-49M | $74M | $64M | $20M | $40M | $63M | $25M | $29M | $85M | $-59M | $8M | $-18M | $-24M | $-727.0K | |
| CapEx | $5M | $5M | $4M | $388.0K | $297.0K | $0 | $453.0K | $70.0K | · | · | $0 | · | · | · | $0 | $0 | |
| Investing Cash Flow | $-9M | $66M | $-56M | $-79M | $-43M | $-124M | $122M | $-82M | $-56M | $-14M | $-347.0K | $34M | $-194M | $193M | $-18M | $15M | |
| Stock Issued | $10M | $4M | $23M | $9M | $16M | $2M | $2M | $268.0K | $4M | $1M | $5M | $13M | $5M | $1M | $2M | $287.0K | |
| Net Stock Activity | · | $4M | · | · | · | $2M | · | · | · | $1M | · | · | · | $1M | · | · | |
| Financing Cash Flow | $10M | $4M | $23M | $9M | $16M | $2M | $2M | $268.0K | $4M | $1M | $5M | $13M | $5M | $1M | $2M | $287.0K | |
| Net Change in Cash | $103M | $105M | $-82M | $4M | $37M | $-102M | $164M | $-19M | $-28M | $16M | $90M | $-12M | $-181M | $176M | $-40M | $15M | |
| Free Cash Flow | · | $29M | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
収益性 7
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 12.3% | -1.7% | · | 12.8% | 12.2% | 7.9% | · | 12.6% | 12.6% | 7.4% | · | -27.3% | 1.8% | -45.2% | · | -23.6% | |
| Net Margin | 10.2% | 1.4% | · | 25.8% | 10.1% | 7.8% | · | 13.1% | 13.8% | 8.0% | · | -30.8% | 0.67% | -36.3% | · | -20.8% | |
| Pretax Margin | 15.1% | 1.5% | · | 16.0% | 15.2% | 11.4% | · | 15.5% | 15.4% | 10.2% | · | -24.6% | 3.8% | -37.9% | · | -20.2% | |
| EBITDA Margin | 12.3% | -1.7% | · | 12.8% | 12.2% | 7.9% | · | 12.6% | 12.6% | 7.4% | · | -27.3% | 1.8% | -45.2% | · | -23.6% | |
| ROA | 2.1% | 0.27% | · | 6.2% | 2.5% | 1.9% | · | 4.1% | 4.3% | 2.2% | · | -10.5% | 0.18% | -6.7% | · | -4.1% | |
| ROE | 3.0% | 0.36% | · | 9.6% | 4.0% | 3.1% | · | 7.0% | 7.3% | 4.0% | · | -16.6% | 0.27% | -10.5% | · | -5.5% | |
| ROIC | 2.0% | -0.34% | · | 6.3% | 2.6% | 1.7% | · | 4.6% | 5.3% | 2.6% | · | -19.9% | 0.13% | -13.7% | · | -7.5% |
流動性と支払能力 2
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.4 | 3.6 | · | 3.0 | 2.9 | 2.9 | · | 2.3 | 2.2 | 2.0 | · | 2.4 | 2.6 | 2.2 | · | 4.5 | |
| Quick Ratio | 1.5 | 1.4 | · | 1.0 | 1.1 | 1.1 | · | 0.7 | 0.8 | 0.9 | · | 0.9 | 1.0 | 1.6 | · | 1.8 |
効率性 3
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.2 | · | 0.2 | |
| Inventory Turnover | 0.3 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.3 | 0.4 | 0.6 | · | 0.8 | 0.6 | 0.1 | · | 0.2 | |
| Receivables Turnover | 2.4 | 2.2 | · | 2.6 | 2.5 | 2.4 | · | 2.6 | 2.6 | 2.6 | · | 2.9 | 2.2 | 1.8 | · | 2.2 |
バリュエーション（TTM） 10
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.12B | $1.06B | · | $1.04B | $1.00B | $943M | · | $929M | $891M | $814M | · | $632M | $551M | $520M | · | $512M | |
| Net Income TTM | $134M | $121M | · | $150M | $112M | $102M | · | $129M | $31M | $-2M | · | $-149M | $-111M | $-146M | · | $-217M | |
| Market Cap | $4.35B | $3.81B | · | $3.61B | $3.64B | $2.78B | · | $2.56B | $2.70B | $3.05B | · | $3.42B | $3.91B | $3.06B | · | $2.65B | |
| P/E | 32.4 | 31.4 | · | 24.0 | 32.2 | 27.2 | · | 19.7 | 90.3 | -1849.0 | · | -22.7 | -34.7 | -20.7 | · | -12.1 | |
| P/S | 3.9 | 3.6 | · | 3.5 | 3.6 | 2.9 | · | 2.8 | 3.0 | 3.7 | · | 5.4 | 7.1 | 5.9 | · | 5.2 | |
| P/B | 3.3 | 3.1 | · | 3.9 | 4.4 | 3.6 | · | 4.4 | 5.2 | 6.6 | · | 9.4 | 9.9 | 8.2 | · | 6.2 | |
| P / Tangible Book | 3.6 | 3.3 | · | 4.5 | 5.1 | 4.3 | · | 5.4 | 6.6 | 8.6 | · | 11.6 | 11.9 | 10.0 | · | 6.2 | |
| P / Cash Flow | · | 112.1 | · | · | · | 136.6 | · | · | · | 104.9 | · | · | · | -170.4 | · | · | |
| P / FCF | · | 132.4 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | 3.1% | 3.2% | · | 4.2% | 3.1% | 3.7% | · | 5.1% | 1.1% | -0.05% | · | -4.4% | -2.9% | -4.8% | · | -8.2% |
財務諸表 損益計算書、貸借対照表、キャッシュフロー — 年次、過去5年間
損益計算書
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 収益 | $1.07B | $958M | $726M | $517M | $484M |
| 粗利益率 % | — | — | 94.3% | 98.0% | 97.8% |
| 営業利益率 % | 9.8% | 24.1% | -10.1% | -43.2% | -35.2% |
| 純利益 | $391M | $226M | $-61M | $-216M | $-168M |
| 希薄化後EPS | $2.30 | $1.36 | $-0.37 | $-1.34 | $-1.05 |
貸借対照表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 流動比率 | 3.8 | 2.4 | 2.4 | 4.0 | 6.4 |
| クイックレシオ | 1.1 | 1.1 | 1.1 | 1.4 | 2.2 |
キャッシュフロー
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| フリーキャッシュフロー | $105M | $157M | $17M | $-114M | $-127M |
最新ニュース この会社に言及した最近の見出し
トレードシグナル エントリー価格とリスク/リワード比率を伴う最近の売買シグナル
マイ指標 あなた専用のウォッチリスト — 決算詳細から選択した行
📊
あなたにとって重要なメトリクスを選択 — 上記の決算詳細の任意の行の横にある➕をクリックしてください。
選択内容は保存され、すべてのティッカーで引き継がれます。
機関投資家（13F） 387 提出者 · $3.2B合計 · 時点 2026年6月30日
四半期SECフォーム13Fでこの株式の保有を報告している機関。ロングポジションのみ。単一の提出者は、別々のオプションレッグで2回表示される場合があります。 大きな反対売買のプット/コール・レッグは、通常、マーケットメイクまたはヘッジされた在庫を反映しており、方向性への確信を示すものではありません。
機関投資家の動向 — Q2 2026 対 前四半期
| 新規ポジション | 解消済みポジション | 増加 | 減少 | 純株式数増減 |
|---|---|---|---|---|
| 56 (+10 前期比) | 37 (+10 前期比) | 136 (+11 前期比) | 100 (-13 前期比) | +17.3M |
Q1 2026と比較しました。 SECフォーム13Fの提出期限は四半期末から45日後ですが、遅延提出者向けの短いバッファーが含まれます。この期間内の四半期は、直近で完全に報告されたペアを優先するためスキップされます。
| 機関投資家 | 評価額 | 株式数 | % 追跡された13Fのうち | タイプ |
|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | $1,085,696,471 | 42,912,904 | 33.44% | 株式数 |
| STATE STREET CORP | $229,628,164 | 9,076,212 | 7.07% | 株式数 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $223,612,785 | 8,838,450 | 6.89% | 株式数 |
| RTW INVESTMENTS, LP | $180,756,457 | 7,144,524 | 5.57% | 株式数 |
| VANGUARD CAPITAL MANAGEMENT LLC | $145,822,875 | 5,763,750 | 4.49% | 株式数 |
| DIMENSIONAL FUND ADVISORS LP | $88,971,384 | 3,516,656 | 2.74% | 株式数 |
| GEODE CAPITAL MANAGEMENT, LLC | $73,088,127 | 2,888,204 | 2.25% | 株式数 |
| Qube Research & Technologies Ltd | $61,899,233 | 2,446,610 | 1.91% | 株式数 |
| Point72 Asset Management, L.P. | $61,559,150 | 2,433,168 | 1.90% | 株式数 |
| CITADEL ADVISORS LLC | $53,414,195 | 2,111,233 | 1.65% | 株式数 |
| Pictet Asset Management Holding SA | $50,146,450 | 1,983,198 | 1.54% | 株式数 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $49,826,959 | 1,969,445 | 1.53% | 株式数 |
| MARSHALL WACE, LLP | $44,649,289 | 1,764,794 | 1.38% | 株式数 |
| BRAIDWELL LP | $41,653,895 | 1,646,399 | 1.28% | 株式数 |
| NORGES BANK | $41,069,692 | 1,623,308 | 1.26% | 株式数 |
| Frazier Life Sciences Management, L.P. | $36,386,409 | 1,438,198 | 1.12% | 株式数 |
| Artisan Partners Limited Partnership | $33,525,890 | 1,325,134 | 1.03% | 株式数 |
| RENAISSANCE TECHNOLOGIES LLC | $32,449,679 | 1,282,596 | 1.00% | 株式数 |
| GOLDMAN SACHS GROUP INC | $32,070,584 | 1,267,612 | 0.99% | 株式数 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $30,520,301 | 1,206,336 | 0.94% | 株式数 |
| D. E. Shaw & Co., Inc. | $28,330,257 | 1,119,773 | 0.87% | 株式数 |
| Allspring Global Investments Holdings, LLC | $26,143,513 | 1,037,441 | 0.81% | 株式数 |
| TWO SIGMA INVESTMENTS, LP | $23,452,898 | 926,992 | 0.72% | 株式数 |
| VANGUARD FIDUCIARY TRUST CO | $23,082,961 | 912,370 | 0.71% | 株式数 |
| BANK OF AMERICA CORP /DE/ | $21,702,062 | 857,789 | 0.67% | 株式数 |
| PANAGORA ASSET MANAGEMENT INC | $17,985,922 | 710,906 | 0.55% | 株式数 |
| Fisher Asset Management, LLC | $17,690,535 | 699,230 | 0.54% | 株式数 |
| Allianz Asset Management GmbH | $15,730,341 | 706,664 | 0.48% | 株式数 |
| RICE HALL JAMES & ASSOCIATES, LLC | $15,657,841 | 618,887 | 0.48% | 株式数 |
| MILLENNIUM MANAGEMENT LLC | $14,925,077 | 589,924 | 0.46% | 株式数 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $14,771,456 | 583,852 | 0.45% | 株式数 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $12,903,000 | 510,000 | 0.40% | 株式数 |
| Hudson Bay Capital Management LP | $11,764,500 | 465,000 | 0.36% | 株式数 |
| GLENMEDE TRUST CO NA | $11,656,544 | 460,733 | 0.36% | 株式数 |
| JUPITER ASSET MANAGEMENT LTD | $11,599,190 | 458,466 | 0.36% | 株式数 |
| Public Sector Pension Investment Board | $11,014,988 | 435,375 | 0.34% | 株式数 |
| MACKENZIE FINANCIAL CORP | $10,646,872 | 420,825 | 0.33% | 株式数 |
| Ishara Investments LP | $10,373,000 | 410,000 | 0.32% | 株式数 |
| TWO SIGMA ADVISERS, LP | $9,888,042 | 370,200 | 0.30% | 株式数 |
| Balyasny Asset Management L.P. | $9,817,007 | 388,024 | 0.30% | 株式数 |
| BlackRock, Inc. | $9,281,482 | 366,857 | 0.29% | 株式数 |
| SPHERA FUNDS MANAGEMENT LTD. | $9,020,310 | 356,534 | 0.28% | 株式数 |
| AMERIPRISE FINANCIAL INC | $8,039,177 | 317,754 | 0.25% | 株式数 |
| PRUDENTIAL FINANCIAL INC | $7,985,313 | 315,625 | 0.25% | 株式数 |
| Alyeska Investment Group, L.P. | $7,850,261 | 310,287 | 0.24% | 株式数 |
| RHUMBLINE ADVISERS | $7,663,389 | 302,902 | 0.24% | 株式数 |
| Schonfeld Strategic Advisors LLC | $7,189,171 | 284,157 | 0.22% | 株式数 |
| Edgestream Partners, L.P. | $7,167,515 | 283,301 | 0.22% | 株式数 |
| Logos Global Management LP | $6,325,000 | 250,000 | 0.19% | 株式数 |
| LAZARD ASSET MANAGEMENT LLC | $6,263,496 | 247,569 | 0.19% | 株式数 |
| FMR LLC | $6,052,317 | 239,222 | 0.19% | 株式数 |
| Swiss National Bank | $5,841,871 | 230,904 | 0.18% | 株式数 |
| VICTORY CAPITAL MANAGEMENT INC | $5,432,213 | 214,712 | 0.17% | 株式数 |
| ALPS ADVISORS INC | $4,985,340 | 197,049 | 0.15% | 株式数 |
| ENVESTNET ASSET MANAGEMENT INC | $4,926,239 | 194,713 | 0.15% | 株式数 |
| Legal & General Group Plc | $4,918,245 | 194,397 | 0.15% | 株式数 |
| FIRST TRUST ADVISORS LP | $4,664,965 | 184,386 | 0.14% | 株式数 |
| NEW YORK STATE COMMON RETIREMENT FUND | $4,364,807 | 172,522 | 0.13% | 株式数 |
| Birchview Capital, LP | $4,326,300 | 171,000 | 0.13% | 株式数 |
| MARTINGALE ASSET MANAGEMENT L P | $4,247,693 | 167,893 | 0.13% | 株式数 |
| Tetragon Partners GP Ltd | $4,247,238 | 167,875 | 0.13% | 株式数 |
| GREAT LAKES ADVISORS, LLC | $3,822,526 | 151,088 | 0.12% | 株式数 |
| AMERICAN CENTURY COMPANIES INC | $3,635,306 | 143,688 | 0.11% | 株式数 |
| STEMPOINT CAPITAL LP | $3,622,125 | 143,167 | 0.11% | 株式数 |
| ALLIANCEBERNSTEIN L.P. | $3,585,329 | 161,066 | 0.11% | 株式数 |
| Squarepoint Ops LLC | $3,542,329 | 140,013 | 0.11% | 株式数 |
| ORBIMED ADVISORS LLC | $3,466,100 | 137,000 | 0.11% | 株式数 |
| Erste Asset Management GmbH | $3,369,240 | 133,700 | 0.10% | 株式数 |
| Emerald Investment Advisers, LLC | $3,333,326 | 131,752 | 0.10% | 株式数 |
| Caption Management, LLC | $3,289,000 | 130,000 | 0.10% | プットオプション |
| VANGUARD ASSET MANAGEMENT, Ltd | $3,130,217 | 123,724 | 0.10% | 株式数 |
| WELLS FARGO & COMPANY/MN | $3,084,475 | 121,916 | 0.09% | 株式数 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $3,077,311 | 138,244 | 0.09% | 株式数 |
| Longaeva Partners L.P. | $2,968,145 | 117,318 | 0.09% | 株式数 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $2,948,791 | 116,553 | 0.09% | 株式数 |
| Trexquant Investment LP | $2,935,357 | 116,022 | 0.09% | 株式数 |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $2,909,778 | 115,011 | 0.09% | 株式数 |
| JONES FINANCIAL COMPANIES LLLP | $2,868,477 | 113,289 | 0.09% | 株式数 |
| Rafferty Asset Management, LLC | $2,789,426 | 110,254 | 0.09% | 株式数 |
| Nan Fung Group Holdings Ltd | $2,605,495 | 102,984 | 0.08% | 株式数 |
| RAYMOND JAMES FINANCIAL INC | $2,406,232 | 95,108 | 0.07% | 株式数 |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $2,344,000 | 92,648 | 0.07% | 株式数 |
| ROYCE & ASSOCIATES LP | $2,324,691 | 91,885 | 0.07% | 株式数 |
| HOHIMER WEALTH MANAGEMENT, LLC | $2,322,540 | 91,800 | 0.07% | 株式数 |
| Point72 Europe (London) LLP | $2,305,047 | 108,015 | 0.07% | 株式数 |
| VIRGINIA RETIREMENT SYSTEMS ET Al | $2,134,076 | 79,898 | 0.07% | 株式数 |
| Campbell & CO Investment Adviser LLC | $2,108,527 | 83,341 | 0.06% | 株式数 |
| Verdad Advisers, LP | $2,090,514 | 82,629 | 0.06% | 株式数 |
| VOYA INVESTMENT MANAGEMENT LLC | $2,072,576 | 81,920 | 0.06% | 株式数 |
| CITADEL ADVISORS LLC | $2,049,300 | 81,000 | 0.06% | コールオプション |
| GUGGENHEIM CAPITAL LLC | $1,979,776 | 78,252 | 0.06% | 株式数 |
| WESBANCO BANK INC | $1,978,460 | 78,200 | 0.06% | 株式数 |
| Phocas Financial Corp. | $1,954,299 | 77,245 | 0.06% | 株式数 |
| MetLife Investment Management, LLC | $1,899,043 | 75,061 | 0.06% | 株式数 |
| STATE OF WISCONSIN INVESTMENT BOARD | $1,850,493 | 73,142 | 0.06% | 株式数 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $1,788,331 | 70,685 | 0.06% | 株式数 |
| Freestone Grove Partners LP | $1,755,643 | 69,393 | 0.05% | 株式数 |
| CenterBook Partners LP | $1,743,878 | 68,928 | 0.05% | 株式数 |
| CANADA PENSION PLAN INVESTMENT BOARD | $1,722,930 | 68,100 | 0.05% | 株式数 |
| Illinois Municipal Retirement Fund | $1,693,380 | 66,932 | 0.05% | 株式数 |
企業インサイダー 37 人のインサイダー · 19人の役員 · 19人の取締役
| インサイダー | 役職 | 最終アクティビティ | 保有株式数 | 12ヶ月購入 | 12ヶ月売却 | 12ヶ月純額 |
|---|---|---|---|---|---|---|
| Stephen Davis | CEO | 2024年1月6日 M | 96,521 | 0 | 0 | $0 |
| Uli Hacksell | CEO | 2011年3月25日 A | 69,916 | 0 | 0 | $0 |
| Elena Ridloff | EVP and CFO | 2021年4月29日 M | 10,553 | 0 | 0 | $0 |
| Todd S. Young | EVP AND CFO | 2018年10月15日 A | — | 0 | 0 | $0 |
| Thomas H Aasen | Exec. VP, CFO & CBO | 2011年3月25日 A | 13,899 | 0 | 0 | $0 |
| Srdjan R. Stankovic | President | 2022年11月21日 M | 61,234 | 0 | 0 | $0 |
| Mark R Brann | President & CSO | 2006年6月16日 S | 317,756 | 0 | 0 | $0 |
| Brendan Teehan | EVP, COO, Head of Commercial | 2024年1月6日 M | 30,949 | 0 | 0 | $0 |
| Elizabeth H.Z. Thompson | EVP, Head of Research & Dev | 2026年7月29日 M | 18,994 | 0 | 2 | $-432,662 |
| James Kihara | PRINCIPAL ACCOUNTING OFFICER | 2026年6月26日 S | 13,088 | 0 | 2 | $-412,253 |
| Austin D. Kim | EVP,General Counsel, Secretary | 2024年1月6日 M | 46,901 | 0 | 0 | $0 |
| Douglas J Williamson | Executive VP, Research & Dev | 2023年2月10日 A | — | 0 | 0 | $0 |
| Michael J. Yang | EVP and CCO | 2021年1月6日 M | 8,059 | 0 | 0 | $0 |
| Eric Alejandro Miller | Controller & PAO | 2019年10月15日 M | 270 | 0 | 0 | $0 |
| Glenn Baity | VP, GC & Sec. | 2011年3月25日 A | — | 0 | 0 | $0 |
| Roger Mills | Executive VP, Development | 2011年3月25日 A | — | 0 | 0 | $0 |
| Bo-Ragnar Tolf | VP/Mg. Dir. ACADIA Pharma AB | 2009年7月8日 M | 20,000 | 0 | 0 | $0 |
| Brian Lundstrom | Sr. VP, Bus. Development | 2008年3月7日 A | 0 | 0 | 0 | $0 |
| Robert E Davis | Exec. VP, Drug Discovery | 2005年3月11日 A | — | 0 | 0 | $0 |
| Adora Ndu | 取締役 | 2026年5月29日 A | 32,908 | 0 | 0 | $0 |
| Elizabeth A. Garofalo | 取締役 | 2026年5月29日 A | 33,489 | 0 | 0 | $0 |
| Jonathan Poole | 取締役 | 2026年5月29日 A | 2,010 | 0 | 0 | $0 |
| James M Daly | 取締役 | 2026年5月29日 A | 12,148 | 0 | 0 | $0 |
| Laura Brege | 取締役 | 2026年5月29日 A | 23,202 | 0 | 0 | $0 |
| Edmund Harrigan | 取締役 | 2026年5月29日 A | 43,148 | 0 | 0 | $0 |
| Daniel B Soland | 取締役 | 2023年6月1日 A | 28,002 | 0 | 0 | $0 |
| Torsten Rasmussen | 取締役 | 2010年6月11日 A | 4,000 | 0 | 0 | $0 |
| Leslie L Iversen | 取締役 | 2010年6月11日 A | 9,000 | 0 | 0 | $0 |
| Mary Ann Gray | 取締役 | 2010年6月11日 A | — | 0 | 0 | $0 |
| Michael T Borer | 取締役 | 2010年6月11日 A | — | 0 | 0 | $0 |
| Lester J Ph D Kaplan | 取締役 | 2010年6月11日 A | 4,000 | 0 | 0 | $0 |
| Gordon M Binder | 取締役 | 2009年6月12日 A | 14,364 | 0 | 0 | $0 |
| Alan G Walton | 取締役 | 2009年6月12日 A | 25,979 | 0 | 0 | $0 |
| Martien Van Osch | 取締役 | 2005年6月10日 A | 1,168,892 | 0 | 0 | $0 |
| GORDON CARL L | 取締役 | 2005年4月20日 A | 774,006 | 0 | 0 | $0 |
| Mark C. Schneyer | — | 2026年8月6日 M | 67,828 | 0 | 3 | $-587,248 |
| John Joseph Kaiser | — | 2008年10月20日 A | — | 0 | 0 | $0 |
SECフォーム3/4/5提出書類からのインサイダー；純額＝公開市場のP/Sのみ
アクティビストおよび5%超のオーナー 6保有
SECスケジュール13Dを提出した投資家 — 発行体の影響を与える意図（アクティビストの保有、取締役会キャンペーン、M&A）を持つ5%超の受益権所有。各行は、その提出者のポジションの最新の既知の状態を示します。
| 提出者 | 提出済み | 保有 | ステータス | 目的 | 提出書類 |
|---|---|---|---|---|---|
| Baker Bros. Advisors LP, Baker Bros. Advisors (GP) LLC, Julian C. Baker, Felix J. Baker, FBB3 LLC ×14 提出書類 | 2026年2月26日 | 25.40% | 修正 | — | SEC |
| Baker Bros. Advisors, LLC, Felix J. Baker, Julian C. Baker ×4 提出書類 | 2013年6月6日 | — | 初回提出 | — | SEC |
| 未開示の報告者, 未開示の報告者, 未開示の報告者 | 2005年5月2日 | — | 初回提出 | — | SEC |
| 未開示の報告者, 未開示の報告者, 未開示の報告者 | 2005年5月2日 | — | 初回提出 | — | SEC |
| 未開示の報告者, 未開示の報告者, 未開示の報告者 | 2005年5月2日 | — | 初回提出 | — | SEC |
| Oxford Bioscience Partners IV L.P., mRNA Fund II L.P., OBP Management IV L.P., Jeffrey T. Barnes, Mark P. Carthy, Jonathan J. Fleming, Michael E. Lytton, Alan G. Walton | 2005年4月29日 | — | 初回提出 | 受動的投資 | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF保有状況 77のETFが保有
ウェイトは直接株式保有（N-PORT）のみを反映しています。レバレッジ型またはデリバティブベースのファンドは、表示されていない追加のスワップエクスポージャーを保有している可能性があります。
| ファンド | ウェイト | 単位 | 時点 | ソース |
|---|---|---|---|---|
| IBRN · iShares Trust | 4.89% | 13,265 SH | 2026年8月8日 | 日次 |
| PBE · Invesco Exchange-Traded Fund Trust | 3.29% | 407,914 SH | 2026年8月8日 | 日次 |
| SBIO · ALPS ETF Trust | 2.35% | 175,740 NS | 2026年5月31日 | N-PORT |
| PSCH · Invesco Exchange-Traded Fund Trust … | 1.87% | 109,972 SH | 2026年8月8日 | 日次 |
| BBP · ETFis Series Trust I | 1.32% | 34,855 NS | 2026年4月30日 | N-PORT |
| RZG · Invesco Exchange-Traded Fund Trust | 1.25% | 59,514 SH | 2026年8月8日 | 日次 |
| LABU · Direxion Shares ETF Trust | 0.85% | 195,542 NS | 2026年4月30日 | N-PORT |
| ROSC · Lattice Strategies Trust | 0.56% | 13,607 NS | 2026年4月30日 | N-PORT |
| IJT · iShares Trust | 0.40% | 1,176,933 SH | 2026年8月8日 | 日次 |
| OASC · Unified Series Trust | 0.39% | 15,269 NS | 2026年5月31日 | N-PORT |
| IBB · iShares Trust | 0.37% | 1,239,145 SH | 2026年8月8日 | 日次 |
| VIOG · VANGUARD ADMIRAL FUNDS | 0.35% | 150,827 SH | 2026年8月8日 | 日次 |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0.34% | 9,317 SH | 2026年8月8日 | 日次 |
| FNY · First Trust Exchange-Traded AlphaDE… | 0.27% | 61,606 NS | 2026年4月30日 | N-PORT |
| BFOR · ALPS ETF Trust | 0.24% | 24,003 NS | 2026年5月31日 | N-PORT |
| QVMS · Invesco Exchange-Traded Fund Trust … | 0.23% | 20,369 SH | 2026年8月8日 | 日次 |
| IWO · iShares Trust | 0.23% | 1,166,817 SH | 2026年8月8日 | 日次 |
| XJR · iShares Trust | 0.23% | 14,974 SH | 2026年8月8日 | 日次 |
| GSSC · Goldman Sachs ETF Trust | 0.20% | 89,945 NS | 2026年5月31日 | N-PORT |
| IJR · iShares Trust | 0.20% | 7,728,433 SH | 2026年8月8日 | 日次 |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.19% | 137,860 SH | 2026年8月8日 | 日次 |
| BIB · ProShares Trust | 0.19% | 6,303 NS | 2026年5月31日 | N-PORT |
| VIOO · VANGUARD ADMIRAL FUNDS | 0.17% | 443,221 SH | 2026年8月8日 | 日次 |
| BKSE · BNY Mellon ETF Trust | 0.17% | 6,035 NS | 2026年4月30日 | N-PORT |
| SMMV · iShares Trust | 0.17% | 17,063 SH | 2026年8月8日 | 日次 |
| SMLF · iShares Trust | 0.15% | 219,745 SH | 2026年8月8日 | 日次 |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0.15% | 47,683 NS | 2026年4月30日 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.14% | 137,072 SH | 2026年8月8日 | 日次 |
| FNX · First Trust Exchange-Traded AlphaDE… | 0.14% | 81,552 NS | 2026年4月30日 | N-PORT |
| SAA · ProShares Trust | 0.12% | 1,498 NS | 2026年5月31日 | N-PORT |
| IWM · iShares Trust | 0.12% | 3,281,125 SH | 2026年8月8日 | 日次 |
| ISCG · iShares Trust | 0.11% | 39,884 SH | 2026年8月8日 | 日次 |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.10% | 741,237 SH | 2026年8月8日 | 日次 |
| RWJ · Invesco Exchange-Traded Fund Trust … | 0.09% | 66,331 SH | 2026年8月8日 | 日次 |
| VBK · VANGUARD INDEX FUNDS | 0.09% | 1,699,377 SH | 2026年8月8日 | 日次 |
| AVSC · AMERICAN CENTURY ETF TRUST | 0.09% | 115,210 NS | 2026年5月31日 | N-PORT |
| DFAS · Dimensional ETF Trust | 0.08% | 526,641 NS | 2026年4月30日 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0.08% | 16,957 NS | 2026年4月30日 | N-PORT |
| ITWO · ProShares Trust | 0.07% | 5,921 NS | 2026年5月31日 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0.06% | 599,784 NS | 2026年5月31日 | N-PORT |
| ISCB · iShares Trust | 0.06% | 5,636 SH | 2026年8月8日 | 日次 |
| FHLC · FIDELITY COVINGTON TRUST | 0.04% | 54,956 NS | 2026年4月30日 | N-PORT |
| IEUS · iShares Trust | 0.04% | 7,411 SH | 2026年8月8日 | 日次 |
| SMDX · Tidal Trust III | 0.04% | 2,306 NS | 2026年4月30日 | N-PORT |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0.04% | 4,033 SH | 2026年8月8日 | 日次 |
| UWM · ProShares Trust | 0.04% | 4,631 NS | 2026年5月31日 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.04% | 1,457,036 SH | 2026年8月8日 | 日次 |
| VB · VANGUARD INDEX FUNDS | 0.04% | 2,944,095 SH | 2026年8月8日 | 日次 |
| PDN · Invesco Exchange-Traded Fund Trust … | 0.04% | 14,209 SH | 2026年8月8日 | 日次 |
| VHT · VANGUARD WORLD FUND | 0.04% | 346,329 SH | 2026年8月8日 | 日次 |